Navigation Links
Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
Date:10/11/2010

iotech.com.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from J&JPRD and/or Johnson & Johnson's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 3, 2010. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Neither J&JPRD nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future events or developments.)


'/>"/>
SOURCE Ortho Biotech Oncology Research & Development
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnsons Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
2. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
3. Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
4. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
5. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
6. Alba Therapeutics Corporation Announces the Next Clinical Trial of Its Lead Compound, Larazotide Acetate and Promotions
7. FDA Advisory Committee Unanimously Recommends Approval of HRA Pharmas Ulipristal Acetate for Emergency Contraception
8. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
9. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
10. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
11. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... and CARDIFF-BY-THE-SEA, Calif. , ... SRNE ;  Sorrento), an oncology company ... and Conkwest, Inc., a privately-held immuno-oncology company developing ... (NK) cell-line based therapy, announced today that the ... jointly develop next generation CAR-TNK™ (pronounced as "Car-Tank") ...
(Date:12/19/2014)... Dec. 18, 2014  Sage Analytics ( www.sageanalytics.com ... equipment for the testing of marijuana potency and ... new Luminary™ Profiler, the industry,s first product suite ... a cost-effective, portable unit. Designed from ... of the cannabis industry, the Luminary™ Profiler utilizes ...
(Date:12/19/2014)... LEXINGTON, Ky. , Dec. 18, 2014 Baptist ... United States to receive full Atrial Fibrillation with ... Patient Care (SCPC). Atrial fibrillation is the most ... concern that in some cases can lead to stroke and ... the United States have atrial fibrillation and the ...
Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3
... 18, 2011 The National Association of Chain ... Association (NCPA) have sent a joint letter ... explaining the importance of pharmacies in Medicaid, offering ... to cut costs without endangering Medicaid beneficiaries, access ...
... Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) today ... AM ET on Thursday, March 3, 2011, to discuss its ... 31, 2010. Financial results are expected to be released on ... financial markets. To participate in the live conference ...
Cached Medicine Technology:NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges 2NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges 3Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call 2Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call 3
(Date:12/21/2014)... 21, 2014 Theme and ... new intro plugin for Final Cut Pro X entitled ... logos, and more with absolute ease.” Said Christiana Austin, ... the tools needed to easily animate their media inside ... Pro X users to animate pictures, videos, logos, and ...
(Date:12/21/2014)... 21, 2014 The Oncology Institute of Hope ... Santa Ana and Whittier offices. The Hope for the Holidays ... of patients and their families during the holiday season. This ... approximately 70 children between both offices. This event continues to ... Target’s community service team, store managers and assistant managers came ...
(Date:12/20/2014)... (PRWEB) December 21, 2014 BambooIndustry.com ... . Recently, the business has announced its bamboo ... buys the best material from certified suppliers, and ... its customers worldwide. In the current promotion, all ... 20% off, when they say they know BambooIndustry.com ...
(Date:12/20/2014)... An improving macroeconomic landscape and a growing ... Massage Services industry over the five years to ... anticipated 1.0% annualized increase in per capita disposable income ... means to afford additional massages. “While the share of ... given year has declined from 2009 to 2012, this ...
(Date:12/20/2014)... 2014 The print component of Healthy ... distribution of approximately 160,000 copies and an estimated readership ... a vast social media strategy and across a network ... the digital version of the campaign, click here ... with the ladies of CTV’s The Social. Lainey ...
Breaking Medicine News(10 mins):Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2
... , , , ... e-Zassi.com(TM), an online decision support software system, integrated business ... has partnered with Medical Development Group (MDG), a medical device ... agreement, MDG will provide access to the e-Zassi platform to ...
... Aug. 12 Hank Oprinski, the CEO at Cap ... tour to inform corporations, chambers of commerce, golfing communities, economic clubs, universities ... , What did all the following businessmen have ... Tiger Woods) , Merv Griffin (TV Producer) , Tom Witter (Dean/Witter/Reynolds) , ...
... , , , ... today that its CardioVasc Advantage(TM) Vascular Reconstruction Device has been ... , "The technology of the Advantage VRD ... noted company Chairman, Eric P. Milledge. "The technical platform behind ...
... , , , ... create expensive home health care costs. Poorly designed mobility aids or ... issue only part of the need is addressed which creates mobility ... alleviated if mobility issues were detected and properly addressed. , ...
... , , LONDON, Aug. ... optimal and efficient way and, at the same time, adhere ... pharmacovigilance tools and technologies. , , (Logo: ... Frost & Sullivan ( http://www.healthcareIT.frost.com ), World Pharmacovigilance Markets ...
... ... A GPS navigation device allows you to most accurately ... above the Earth’s surface - instantly. This multi-perspective triangulation clearly leads ... performance measurement system incorporates a number of key vital signs from ...
Cached Medicine News:Health News:Medical Development Group Partners with e-Zassi.com(TM) to Provide Members Access to Exciting New Software Tool 2Health News:Medical Development Group Partners with e-Zassi.com(TM) to Provide Members Access to Exciting New Software Tool 3Health News:September is Prostate Cancer Awareness Month 2Health News:Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction Device 2Health News:Expensive Health Care: Undetected, Unmet Mobility Needs Creating Boomer & Senior Health Care Costs 2Health News:Frost & Sullivan: Outsourcing/Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 2Health News:Frost & Sullivan: Outsourcing/Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 3Health News:Utilizing GPS-like Measurement Precision To More Accurately Determine Overall Performance 2Health News:Utilizing GPS-like Measurement Precision To More Accurately Determine Overall Performance 3
... Spheres for Enucleation and Evisceration. ... the structure of standard MEDPOR Spheres ... The Bioglass component, mixed throughout the ... ingrowth into the MEDPOR PLUS sphere., ...
... Collamer ICL and the TORIC ICL are ... Collamer, STAARs proprietary collagen copolymer, the lens ... sulcus. This unique material contains a small ... and superior optical capability. The lens is ...
... refractive lens technology for the phakic ... efficacy, demonstrates quality of vision and ... correction. The lens is compatible with ... now available for the correction of ...
Soft, pliable latex straps for securing electrodes are 56 cm (21 in) long and 1.8 cm (0.75 in) wide. Holes for use with posted ground electrodes are spaced 4 cm (1.5 in) apart....
Medicine Products: